A study of diabetic retinopathy in type 2 diabetic patients and its relation with diabetic progression
DOI:
https://doi.org/10.36320/ajb/v10.i1.8203Keywords:
diabetic retinopathy, fungicide Bentazole, biosynthesisAbstract
The study aimed to investigate the diabetic retinopathy in type 2 diabetic patients and its relation with the glycemic control represented with the glycatedhaemoglobin (HbA1c). The study performed in the diabetic and endocrinology center at Al-Sader medical city in Al-Najaf Al-Ashraf. The study included 102 subjects, divided into a (10) healthy subjects ascontrol group and two groups of diabetic patients attended to the diabetic and endocrinology center at Al-Sader medical city and diagnosed as type 2 diabetic patients, divided into two groups with and without retinopathy. The type of retinopathy was determined by physicians, there are three retinopathy subtypes: diabetic retinopathy in early stages, proliferative retinopathy and macular edema.Most DR patients were in early stages of retinopathy 37.25%, proliferative diabetic retinopathy 11.76%, and macular edema 11.76%.The results shows a significant increase of diabetic retinopathy DR prevalence with increasing diabetic duration, the incidence of DR was highest in patients of 15-20 years of diabetes mellitus,and the highest were the proliferative , then macular edema 12.33 ± 18.6 and 14.16 ± 2.32 respectively. The level of fasting plasma glucose among control, DM and DR groups increased significantly (P < 0.05), while there was no significant differences (P < 0.05) in FPG levels between these subtypes of DR.
The HbA1c was significantly highest (P<0.05 )in DM and DR (6.65% ± 0.29 and 8.025 ± 0.19 respectively) when compared with 5.73% ± 0.18 in the control group. According to the successive HbA1c percentiles,the early stages of DR were found in all levels of HbA1c, but the highest incidence were in the highest levels. Also proliferative DR begin to appear at 7-7.5 % of HbA1c, andits highest incidence were at 7.5 – 8 %. Macular edema increased at 7-7.5% and at levels highest than 10.5 %.There was a significant decrease in body mass index BMI in DR patients when compared with other groups, and a significant decrease in BMI in proliferative DR and macular edema when compared with the control.
The study concluded that there is a critical need to perform a periodical check to diabetic patients to diagnose the retinopathy in its early appearance, and to use the glycosylated haemoglobin as measurement periodically to detect any increase or fluctuation in this parameter to control the glycemic state in these patients.
Downloads
References
Kempen J.H., Colmain B.J., Leske M.C., Haffner S.M., Klein R., Moss S.E., Taylor H.R., Hammann R.F. 2004. The prevalence of diabetic retinopathy among adults in theUnited States. Arch.Ophthalmol. 122:552-563.
Bhavsar A.R.2012.Diabetic Retinopathy, Medscape, Jun, 86: 134-152.
Wong T.Y., Cheung N., Tay W.T., Wang J.J., Aung.T., Saw S.M. 2008. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology, 115(11):1869–1875.
Ockrim Z., Yorston D. 2010. Managing diabetic retinopathy. BMJ. Oct 25;341:c5400.
Oh E., Yoo T.K. and Park E.C. 2013. Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. Medical Informatics and Decision Making, 13:106.
Mbenza B.L., Muaka M.M., Mbenza G., Mbungu-Fuele S., Mabwa-Mbalanda l., Nzuzi- Babeki V., Mbadi-A-Sungu J.(2008) Risk factors of poor control of HBA1c and diabetic retinopathy: Paradox with insulin therapy and high values of HDL in African diabetic patients. Int. J. Diabetes & Metabolism 16: 69-78
Patel J.I., Tombran-Tink J., Hykin P.G., Gregor Z.J., Cree I.A.( 2006) Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macula edema:Implications for structural differences in macular profiles. Exp. Eye. Res., 82:798-806.
Trivelli L.A., Ranney H.M. and Lai H.T.. (1971). Hemoglobin components in patients with diabetes mellitus. N. Engl. J. Med., 284: 353-357.
Trinder P. (1969). Determination of glucose in blood using oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem., 6: 24-27.
Cheung N., Wong T.Y.( 2008) Diabetic retinopathy and systemic vascular complications. Prog.Retin. Eye Res., 27(2):161–176.
Liew G., Wong T.Y., Mitchell P., Cheung N., Wang J.J.( 2008) Retinopathy predicts coronary heart disease mortality. Heart, 95(5):391–394
Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J.( 2010) Prevalence of diabetes among Men and women in china. N Engl J Med, 362(12):1090–1101.5
RaA.S.( 2012): Predictors for diabetic retinopathy in normoalbuminuric people with type 2 diabetes mellitus. Diabetology&Metabolic Syndrome 4:29
Pang C., Jia L., Jiang S., Liu W., Hou X., Zuo Y.( 2012) Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diab./Metab. Res. Reviews, 28(3):276–283
Wong T.Y., Liew G., Tapp R.J.( 2008) Relation between fasting glucose and retinopathy for diagnosis of diabetes: three Lancet. Mar 1;371(9614):736-43
Kim J.H., Kwon H.S., Park Y.M., Lee J.H., Kim M.S., Yoon K.H.( 2011) Prevalence and associated factors of diabetic retinopathy in rural Korea: the chungjumetabolic disease cohort study. J. Korean Med. Sci., 26(8):1068.
Xu J., Wei W.B., Yuan M.X., Yuan S.Y., Wan G., Zheng Y.Y.( 2012) Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetesstudy 6. Retina, 32(2):322–329
ChengY.J., Gregg E.W., Geiss L., Imperatore G., Williams D.E., Zhang X., Albright A.L., Cowi C.C., Klein R.( 2009) Association of A1C and Fasting PlasmaGlucose Levels With Diabetic RetinopathyPrevalence in the U.S. Population Diabetes Care 32:2027–2032.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Dr. Ikhlass Ali Hussein Al-Hilaly
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
